Summary of Latest Developments in the Prostate Specific Antigen (PSA) Testing Market

1
Prostate Specific Antigen (PSA) Testing Market
analysis and drive growth by 2023
2
Europe dominates the Prostate Specific Antigen
(PSA) Testing Market in the forecast period
  Europe has a larger share of the Prostate
Specific Antigen (PSA) Market. It is expected to
reach 1238.8 Million by 2023 with a CAGR of
3.37 in the coming years. The growing
competition among the service providers is
propelling the growth of the market in the
region. The growth of PSA testing procedures in
North America is attributed to the focus on
healthcare. US is the most developed country in
the world and has well established healthcare
facilities. PSA screening is advantageous to men
in the region, especially selected patients. In
Mexico, prostate specific antigen testing has
been implemented in many of its clinic and
laboratories. More number of men suffer from
prostate cancer in this region. Hence, the need
for new diagnostic tools and testing methods has
spurred the growth of the Prostate Specific
Antigen (PSA) Testing Market during the forecast
period.
Contact sales_at_industryarc.com
3
Selective type of Regulatory Analysis done in the
full report
Free Prostate Specific Antigen Test, also known
as FPSA is a major PSA blood test. It uses a
blood sample of a man to carry out the test. FPSA
is described as the amount of PSA in blood that
circulates freely. The test only measures the
FPSA which is not bounded to the proteins in the
blood. It can predict the risk of prostate cancer
in men.   There are some advantages of FPSA
since it reduces the risk of infection. The
increasing number of free PSA tests in hospitals
and clinics has resulted in the reduction in the
use of the number of biopsies. This has a
positive impact on the growth of the Prostate
Specific Antigen (PSA) Testing Market.
Contact sales_at_industryarc.com
4
Excerpts on market growth factors

• Prostate specific antigen test can detect a fast
  growing cancer at an early stage. This stops the
  cancer from spreading. Regular PSA tests can be
  helpful for men. This factor drives the growth of
  the market.
• Improvements in the PSA tests by scientists and
  regulatory agencies can help the doctors to
  differentiate between slow growing cancers and
  potentially lethal cancers. Rising cases of
  Prostate cancer also drive the demand for PSA
  Testing.
• The mortality rate has reduced to 23.8 from 23.6.
  This indicates that the PSA test is very
  effective in determining prostate cancer.
• Screening approaches in the US and Europe have
  reduce the mortality rate of prostate cancer in a
  faster way.

Contact sales_at_industryarc.com
5
Key Players of the Prostate Specific Antigen
(PSA) Testing Market

• MDxHealth
• SPECTRA LABORATORIES
• BIOMERIEUX
• SIEMENS HEALTHCARE GmbH
• GlaxoSmithKline
• F. HOFFMANN-LA ROCHE AG
• Company 10

Download Sample Report
Contact sales_at_industryarc.com
6
You Can Customize the Report as Per Your Need. We
have included Some Customization Options
Company Profile
Analyst Briefing
Data Tables
Key Contacts
Contact sales_at_industryarc.com
7
About IndustryARC
IndustryARC is a research and consulting firm
that publishes more than 500 reports annually in
various industries, such as Agriculture,
Automotive, Automation Instrumentation,
Chemicals and Materials, Energy and Power,
Electronics, Food Beverages, Information
Technology, Life sciences Healthcare. IndustryA
RC primarily focuses on Cutting Edge Technologies
and Newer Applications of the Market. Our Custom
Research Services are designed to provide
insights on the constant flux in the global
demand-supply gap of markets. Our strong analyst
team enables us to meet the client research needs
at a very quick speed with a variety of options
for your business.
Contact sales_at_industryarc.com